Related Experiment Video
Updated: Jun 6, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular Risk Factors in Patients with Valvular Heart Disease: A Nationwide Observational Cohort Study
Qianhong Lu1,2, Junxing Lv1,2,3,4, Zhe Li1,2
1Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, People's Republic of China.
Conventional cardiovascular risk factors increase the risk of adverse outcomes in patients with valvular heart disease (VHD), particularly mitral regurgitation. Managing these risk factors is crucial for improving patient prognosis and secondary prevention strategies.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Valvular heart disease (VHD) is a significant cardiovascular condition.
- Conventional cardiovascular risk factors are increasingly recognized as potential contributors to VHD development and progression.
Purpose of the Study:
- To investigate the prevalence of modifiable cardiovascular risk factors (smoking, hypertension, hyperlipidemia, diabetes) in patients with VHD.
- To assess the impact of these risk factors on patient outcomes.
- To identify prognostic indicators in VHD patients with varying risk factor burdens.
Main Methods:
- A cohort study involving 11,862 patients with moderate or greater VHD.
- Primary outcome: a composite of all-cause mortality, heart failure hospitalization, and myocardial infarction within two years.
- Analysis of risk factor distribution and their association with outcomes, stratified by VHD type and etiology.
Main Results:
- The study included 11,862 patients with VHD, with a mean age of 61.77 years and 44.4% females.
- Prevalence of risk factors: hypertension (45.0%), smoking (14.9%), diabetes (14.5%), and hyperlipidemia (13.4%).
- An increasing number of risk factors was independently associated with poorer two-year outcomes in patients with mitral regurgitation (MR), with a 17.3% higher risk of adverse events per additional risk factor in secondary MR. Females with three or four risk factors had poorer outcomes than males.
Conclusions:
- Over 20% of VHD patients had at least two conventional cardiovascular risk factors.
- The number of risk factors is a significant indicator of poor prognosis in patients with significant MR.
- Optimizing the management of cardiovascular risk factors is essential for improving secondary prevention and long-term outcomes in VHD patients.
More Related Videos
12:12Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...